DV

Daniel Dorado Villa

Director Of Finance Fp&a at Akron Bio

Daniel Dorado Villa has a diverse work experience starting from 2014. Daniel worked as a Summer Research Assistant at the Department of Pharmaceutical & Biomedical Sciences at UGA in 2014. From 2016 to 2017, they served as the Director of Graduate & Professional Student Association at Florida Atlantic University, where they advocated for the needs of graduate-professional students and coordinated efforts with various university departments. In 2017, they worked as an Expense Specialist and then as a Senior Accountant at Florida Atlantic University. From 2018 to 2019, they held the position of Assistant Director Student Affairs, Finance at Florida Atlantic University, where they managed budgets and supervised staff. In 2019, they joined Newell Brands as a Financial Analyst, and later became a Senior Financial Analyst, responsible for developing financial forecasts/plans and analyzing variances. Most recently, Daniel joined Akron Bio in 2022 as a Senior Financial Analyst, and later assumed the role of Financial Planning and Analysis Manager.

Daniel Dorado Villa has a diverse educational background. Daniel earned a Bachelor of Science (BS) in Biology, General from Florida Gulf Coast University from 2010 to 2013. In 2016, they pursued further education at Florida Atlantic University, where they completed several programs. Daniel completed the Financial Analyst Program in Finance from 2016 to 2017, and simultaneously pursued a Master of Business Administration (M.B.A.) in Business Administration and Management, Finance from 2016 to 2018. Additionally, Daniel briefly attended Barry University in 2016 for a Professional Science Masters in Professional Science. While not specified, it is mentioned that they have obtained the Bloomberg Market Concepts certification from Bloomberg LP at an unspecified time.

Location

Mooresville, United States

Links

Previous companies


Org chart

No direct reports

Teams


Offices

This person is not in any offices


Akron Bio

Akron has a strategic focus on the discovery, development and manufacturing of innovative tools and technologies, and providing services for the regenerative medicine industry. As a compliant global manufacturer, Akron develops and supplies innovative solutions to key problems in the tissue engineering, cell and gene therapy industry. These includecGMP growth factors, culture media, recombinant and human proteins, novel cryopreservation media, delivery technologies and bioengineered scaffolds for discovery, development, and commercialization. Their company’s unique business model emphasizes flexibility, quality, and unparalleled service—from research and development through clinical trial, market authorization, and commercial product.